Abstract
Dysregulation of intracellular pH ($pH_i$) is a hallmark of cancer cells, which maintain homeostasis to support malignancy. Alkaliptosis, a pH-dependent regulated cell death triggered by the small molecule JTC-801, offers a new therapeutic target. This study establishes a stable RpHluorin2-expressing cell line and a multi-dimensional fluorescence detection workflow to monitor dynamic $pH_i$ changes during alkaliptosis across various scales, from high-throughput screening to single-cell analysis.
Introduction
Cancer cells exploit intracellular pH to sustain proliferation and invasion. While the tumor microenvironment is typically acidic, the interior of a cancer cell remains neutral or slightly alkaline to fuel growth. Alkaliptosis is a recently identified form of cell death driven by intracellular alkalization, specifically induced by JTC-801. Monitoring these dynamic pH shifts is crucial for developing pH-targeted therapies, yet traditional dyes often lack the stability or versatility required for comprehensive analysis.
Methodology: The RpHluorin2 Platform
To address these limitations, researchers engineered the human bladder cancer cell line (5637) to stably express RpHluorin2, an optimized, ratiometric, pH-sensitive green fluorescent protein variant. RpHluorin2 provides enhanced brightness and stability compared to previous sensors.
The study introduced a multi-dimensional workflow integrating five detection methods:
- Microplate Reader for rapid, high-throughput quantification.
- Fluorescence Microscopy for direct visualization of subcellular changes.
- Flow Cytometry for analyzing pH distributions at the single-cell level.
- IVIS Spectrum for high-resolution well-plate mapping.
- Protein Dot Blot Assay to analyze cell lysates, confirming that pH-induced protein states are preserved after lysis.
Key Results and Insights
The platform demonstrated exceptional reliability, with a near-perfect linear correlation ($R^2 = 0.9998$) between cell number and fluorescence intensity.
Monitoring Alkaliptosis
As JTC-801 induces alkaliptosis, the resulting rise in $pH_i$ causes a dose- and time-dependent reduction in RpHluorin2 fluorescence. This inverse relationship—where less fluorescence indicates more alkalization—allows for precise tracking of the cell death process. Flow cytometry confirmed that JTC-801 induces a uniform shift across the entire cell population, indicating a consistent response to the treatment.
Biochemical "Snapshots"
A significant finding was the stability of the RpHluorin2 signal in cell lysates. The protein's pH-dependent conformational state is "locked" during low-temperature lysis and membrane fixation. This allows researchers to perform biochemical validation via dot blots that accurately reflect the live-cell pH at the exact moment of harvest.
Conclusion
This multi-dimensional platform provides a robust toolkit for studying alkaliptosis and screening pH-modulating drugs. While currently focused on bladder cancer cells and JTC-801, future work will expand to other cancer types and in vivo monitoring to further bridge the gap between cellular research and clinical application.
Summary updated